Glycosylated SV2A and SV2B Mediate the Entry of Botulinum Neurotoxin E into Neurons
- 1 December 2008
- journal article
- Published by American Society for Cell Biology (ASCB) in Molecular Biology of the Cell
- Vol. 19 (12), 5226-5237
- https://doi.org/10.1091/mbc.e08-07-0765
Abstract
Botulinum neurotoxin E (BoNT/E) can cause paralysis in humans and animals by blocking neurotransmitter release from presynaptic nerve terminals. How this toxin targets and enters neurons is not known. Here we identified two isoforms of the synaptic vesicle protein SV2, SV2A and SV2B, as the protein receptors for BoNT/E. BoNT/E failed to enter neurons cultured from SV2A/B knockout mice; entry was restored by expressing SV2A or SV2B, but not SV2C. Mice lacking SV2B displayed reduced sensitivity to BoNT/E. The fourth luminal domain of SV2A or SV2B alone, expressed in chimeric receptors by replacing the extracellular domain of the low-density lipoprotein receptor, can restore the binding and entry of BoNT/E into neurons lacking SV2A/B. Furthermore, we found disruption of a N-glycosylation site (N573Q) within the fourth luminal domain of SV2A rendered the mutant unable to mediate the entry of BoNT/E and also reduced the entry of BoNT/A. Finally, we demonstrate that BoNT/E failed to bind and enter ganglioside-deficient neurons; entry was rescued by loading exogenous gangliosides into neuronal membranes. Together, the data reported here demonstrate that glycosylated SV2A and SV2B act in conjunction with gangliosides to mediate the entry of BoNT/E into neurons.Keywords
This publication has 61 references indexed in Scilit:
- Mechanism of botulinum neurotoxin B and G entry into hippocampal neuronsThe Journal of cell biology, 2007
- Single molecule detection of intermediates during botulinum neurotoxin translocation across membranesProceedings of the National Academy of Sciences of the United States of America, 2007
- Association of Botulinum Neurotoxin Serotypes A and B with Synaptic Vesicle Protein ComplexesBiochemistry, 2007
- Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor conceptProceedings of the National Academy of Sciences of the United States of America, 2007
- SNAREs — engines for membrane fusionNature Reviews Molecular Cell Biology, 2006
- SV2 Is the Protein Receptor for Botulinum Neurotoxin AScience, 2006
- The high‐affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1aFEBS Letters, 1996
- Implications of the SNARE hypothesis for intracellular membrane topology and dynamicsCurrent Biology, 1994
- The SV2 Protein of Synaptic Vesicles Is a Keratan Sulfate ProteoglycanJournal of Neurochemistry, 1993
- Evidence for direct binding of Clostridium botulinum type E derivative toxin and its fragments to gangliosides and free fatty acidsBiochemical and Biophysical Research Communications, 1986